• LAST PRICE
    0.7760
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.7769/ 4
  • Ask / Lots
    0.8200/ 2
  • Open / Previous Close
    --- / 0.7760
  • Day Range
    ---
  • 52 Week Range
    Low 0.3600
    High 1.9200
  • Volume
    39
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 0.7763
TimeVolumeVERU
09:32 ET147910.7677
09:34 ET15610.7699
09:38 ET1250.7739
09:39 ET120110.7842
09:41 ET45470.774
09:43 ET7000.774
09:45 ET7000.774
09:48 ET31450.771
09:56 ET10000.776723
10:03 ET7340.7735
10:06 ET11000.784299
10:08 ET5060.7736
10:12 ET665490.765
10:14 ET143690.7741
10:15 ET1000.7677
10:17 ET7600.7691
10:19 ET1000.7677
10:21 ET27000.768
10:24 ET3600.7705
10:26 ET2000.7697
10:28 ET7320.7697
10:30 ET8580.7677
10:32 ET15000.7698
10:33 ET13180.7698
10:35 ET13460.7698
10:37 ET2000.7697
10:39 ET7320.7697
10:44 ET14150.7698
10:46 ET1000.7696
10:48 ET3570.76975
10:51 ET4000.7721
10:53 ET1000.7739
10:55 ET10000.771214
10:57 ET21770.77
11:00 ET2000.7675
11:02 ET98630.769499
11:06 ET1000.7695
11:08 ET3000.7658
11:09 ET4500.769199
11:11 ET2000.7623
11:13 ET50550.7692
11:20 ET30000.7691
11:29 ET19470.7673
11:31 ET17000.77
11:36 ET31000.7721
11:40 ET1000.7705
11:42 ET2000.7739
11:45 ET38850.7703
11:47 ET2000.7703
11:49 ET53000.7718
11:51 ET8110.7681
11:54 ET52000.7699
11:56 ET3000.7652
12:00 ET21700.7652
12:07 ET39750.769049
12:12 ET1000.7665
12:14 ET30440.7665
12:16 ET13000.7685
12:18 ET11600.77
12:21 ET25100.7723
12:23 ET2210.7722
12:25 ET11000.7719
12:30 ET94290.7708
12:32 ET2440.7707
12:36 ET1000.7707
12:38 ET14000.7707
12:39 ET70960.7722
12:41 ET109000.77315
12:43 ET54000.773889
12:45 ET125010.7766
12:48 ET2000.7766
12:50 ET1020.7778
01:06 ET72340.7779
01:08 ET4000.7779
01:10 ET5000.7779
01:12 ET4500.7779
01:14 ET3130.7779
01:21 ET389200.7679
01:24 ET13000.7695
01:26 ET1000.76765
01:28 ET2000.7676
01:32 ET236320.77
01:33 ET5000.7699
01:35 ET5000.7684
01:37 ET3000.7699
01:46 ET1000.7679
01:51 ET14340.77
01:53 ET1690.7699
01:55 ET26220.76975
01:57 ET26000.7697
02:00 ET4130.76975
02:02 ET8000.7698
02:04 ET3230.7698
02:06 ET38000.7697
02:08 ET1000.7694
02:13 ET10300.7698
02:15 ET2000.7694
02:20 ET1000.7689
02:22 ET7020.7698
02:27 ET43000.7698
02:29 ET42000.7693
02:33 ET32000.7693
02:36 ET4000.7693
02:38 ET6400.7692
02:42 ET1057870.7775
02:44 ET120980.7899
02:45 ET47000.7898
02:47 ET21000.78989
02:49 ET2760.79
02:56 ET2000.789
02:58 ET34530.7947
03:00 ET4000.7955
03:03 ET6000.7986
03:05 ET5380.7986
03:12 ET6580.7985
03:14 ET27300.7985
03:16 ET28370.7985
03:18 ET46120.798
03:25 ET5750.79091
03:30 ET2340.7946
03:32 ET135560.7987
03:34 ET14000.7988
03:36 ET60000.7988
03:38 ET27220.7989
03:39 ET11260.7989
03:41 ET6050.799
03:43 ET29140.799
03:45 ET233110.8049
03:48 ET1000.8049
03:50 ET66300.7922
03:52 ET5250.7939
03:54 ET7880.7924
03:56 ET14140.792
03:57 ET37100.792
03:59 ET543390.776
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVERU
Veru Inc
113.6M
-2.2x
---
United StatesSPCO
Stephan Co
4.6M
-0.5x
---
United StatesAXIL
AXIL Brands Inc
28.6M
17.3x
---
United StatesCAWW
CCA Industries Inc
5.3M
-21.9x
---
United StatesDSY
Big Tree Cloud Holdings Ltd
194.1M
-311.4x
---
United StatesNXRA
Nextera Enterprises Inc
40.0
0.0x
---
As of 2024-09-27

Company Information

Veru Inc. is a biopharmaceutical company. The Company is focused on developing medicines for the for the treatment of hospitalized COVID-19 patients at high risk for acute respiratory distress syndrome (ARDS) and other viral-related ARDS and for the management of breast and prostate cancers. The Company offers two FDA approved products within its sexual health program, including ENTADFI (tadalafil 5mg and finasteride 5mg capsule), for the treatment of benign prostatic hyperplasia and FC2 Female Condom (internal condom) (FC2), for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. Its breast cancer drug pipeline has four clinical development programs for two drugs, such as enobosarm, an oral selective androgen receptor targeting agonist, and sabizabulin, an oral cytoskeleton disruptor. Its prostate cancer drug pipeline includes sabizabulin, VERU-100 and zuclomiphene citrate.

Contact Information

Headquarters
2916 N. MIAMI AVENUE, SUITE 1000MIAMI, FL, United States 33127
Phone
312-595-9123
Fax
312-595-9122

Executives

Chairman of the Board, President, Chief Executive Officer
Mitchell Steiner
Vice Chairman of the Board, Chief Corporate Officer
Harry Fisch
Chief Financial Officer, Chief Administrative Officer
Michele Greco
Chief Scientific Officer
K. Gary Barnette
Independent Director
Mario Eisenberger

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$113.6M
Revenue (TTM)
$14.1M
Shares Outstanding
146.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
-0.48
EPS
$-0.35
Book Value
$0.21
P/E Ratio
-2.2x
Price/Sales (TTM)
8.1
Price/Cash Flow (TTM)
---
Operating Margin
-281.09%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.